Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Naltrexone And Bupropion

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1742

NCT00532779

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
NB16155 participants36 participants31 participantsn/rn/r
NB32171 participants56 participants26 participantsn/rn/r
Placebo30 participants14 participants28 participantsn/rn/r

A count stays a count. This page does not turn a count into a percent.